Literature DB >> 12393173

Quantitative evaluation of expression of iron-metabolism genes in ceruloplasmin-deficient mice.

Kanji Yamamoto1, Kunihiro Yoshida, Yuko Miyagoe, Aki Ishikawa, Kazunori Hanaoka, Shozo Nomoto, Kazuma Kaneko, Shu-ichi Ikeda, Shin'ichi Takeda.   

Abstract

Aceruloplasminemia is an autosomal recessive disorder caused by mutations in the ceruloplasmin (CP) gene, and is characterized by a unique combination of neurovisceral iron overload and iron deficiency anemia. We generated CP-deficient (CP(-/-)) mice to investigate the functional involvement of CP in iron metabolism. The mice showed a marked iron overload in the liver and mild iron deficiency anemia. We examined the expression of iron-metabolism genes in the duodenum and liver using TaqMan RT-PCR. The divalent metal transporter 1 (DMT1), ferroportin 1 (FPN1), and hephaestin (HEPH) genes were not up-regulated in the duodenum from CP(-/-) mice. These data suggest that the mechanism of hepatic iron overload in aceruloplasminemia is quite different from that in hemochromatoses and atransferrinemia. In the liver, CP(-/-) mice showed no increase of gene expression for DMT1 and transferrin receptors (TFR and TFR2), indicating that none of the known pathways of iron uptake is activated in hepatocytes of CP(-/-) mice. This result supports the hypothesis that CP mainly acts to release iron from cells in the liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393173     DOI: 10.1016/s0925-4439(02)00165-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease.

Authors:  Bakytzhan Bakhautdin; Maria Febbraio; Esen Goksoy; Carol A de la Motte; Muhammet F Gulen; Erin Patricia Childers; Stanley L Hazen; Xiaoxia Li; Paul L Fox
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

Review 2.  Impact of copper limitation on expression and function of multicopper oxidases (ferroxidases).

Authors:  Joseph R Prohaska
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

3.  Ceruloplasmin Deficiency Impaired Brain Iron Metabolism and Behavior in Mice.

Authors:  Lijing Niu; Yi Zhou; Li Lu; Aixia Su; Xiaoqiang Guo
Journal:  Cell Biochem Biophys       Date:  2022-02-11       Impact factor: 2.989

4.  Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice.

Authors:  Mitchell L Klebig; Melissa D Wall; Mark D Potter; Erica L Rowe; Donald A Carpenter; Eugene M Rinchik
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

5.  Copper-induced ferroportin-1 expression in J774 macrophages is associated with increased iron efflux.

Authors:  Jayong Chung; David J Haile; Marianne Wessling-Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

6.  Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke.

Authors:  Sarah J Texel; Jian Zhang; Simonetta Camandola; Erica L Unger; Dennis D Taub; Raymond C Koehler; Z Leah Harris; Mark P Mattson
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

7.  Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity.

Authors:  Akiyo Hineno; Kazuma Kaneko; Kunihiro Yoshida; Shu-ichi Ikeda
Journal:  Neurochem Res       Date:  2011-06-26       Impact factor: 3.996

Review 8.  Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Authors:  Sonia Levi; Dario Finazzi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

9.  Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.

Authors:  Alan Zanardi; Antonio Conti; Marco Cremonesi; Patrizia D'Adamo; Enrica Gilberti; Pietro Apostoli; Carlo Vittorio Cannistraci; Alberto Piperno; Samuel David; Massimo Alessio
Journal:  EMBO Mol Med       Date:  2018-01       Impact factor: 12.137

10.  Investigation of iron metabolism in mice expressing a mutant Menke's copper transporting ATPase (Atp7a) protein with diminished activity (Brindled; Mo (Br) (/y) ).

Authors:  Sukru Gulec; James F Collins
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.